{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:46:12Z","timestamp":1793159172104,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thyroid diseases may cause a variety of functional and structural body changes, including eye and vision abnormalities, which can have a negative impact on a patient\u2019s well-being. However, only a few studies on the impact of other benign thyroid diseases on the visual process are available in the literature. In this study, using the Polish version of the thyroid-specific quality of life (ThyPROpl) questionnaire, we aimed to determine the self-reported influence of benign thyroid diseases (e.g., nodular goiter, toxic nodular goiter, Graves\u2019 disease, thyroid orbitopathy, Hashimoto\u2019s thyroiditis, and surgical hypothyroidism) on patients\u2019 eyes and vision. This was a prospective study. In total, 374 randomly selected euthyroid patients and 255 control subjects responded to the ThyPROpl questionnaire and the results were evaluated. Nearly 69% of the respondents reported that the most frequent condition was \u201creduced sight.\u201d Men most often reported wet\/tearing eyes (66%). The occurrence of eyelid sacks or swollen eyelids (64%), ophthalmalgia (62%), and eye dryness (61%) was marked almost as often. In total, 29% of the patients reported diplopia, and it was found to be most prevalent among those with thyroid orbitopathy. Other complaints were similarly prevalent among all the subgroups. A positive correlation was also observed between the scores of the \u201ceye symptoms\u201d and other ailments. Except for swelling around the lower eyelids, patients with thyroid diseases more frequently experienced all of the ocular complaints analyzed in this study compared with controls. This study showed that eye complaints are common in patients with benign thyroid diseases and ocular disturbances have a negative impact on the overall quality of life of patients.<\/jats:p>","DOI":"10.1038\/s41598-021-98232-0","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T10:21:27Z","timestamp":1632219687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Eye symptoms in patients with benign thyroid diseases"],"prefix":"10.1038","volume":"11","author":[{"given":"Nadia","family":"Sawicka-Gutaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Zi\u00f3\u0142kowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Wojciechowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Shawkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Czarnywojtek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Warcho\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Sowi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Szczepanek-Parulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Rucha\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"98232_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1530\/eje.1.02124","volume":"154","author":"T Watt","year":"2006","unstructured":"Watt, T. et al. Quality of life in patients with benign thyroid disorders. A review. Eur. J. Endocrinol. 154, 501\u2013510. https:\/\/doi.org\/10.1530\/eje.1.02124 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"98232_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/ICU.0b013e3283131557","volume":"19","author":"AE Kuriyan","year":"2008","unstructured":"Kuriyan, A. E., Phipps, R. P. & Feldon, S. E. The eye and thyroid disease. Curr. Opin. Ophthalmol. 19, 499\u2013506. https:\/\/doi.org\/10.1097\/ICU.0b013e3283131557 (2008).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"98232_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/thy.2009.0199","volume":"20","author":"H Tjiang","year":"2010","unstructured":"Tjiang, H., Lahooti, H., McCorquodale, T., Parmar, K. R. & Wall, J. R. Eye and eyelid abnormalities are common in patients with Hashimoto\u2019s thyroiditis. Thyroid 20, 287\u2013290. https:\/\/doi.org\/10.1089\/thy.2009.0199 (2010).","journal-title":"Thyroid"},{"key":"98232_CR4","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1210\/jc.2016-1220","volume":"101","author":"GJ Kahaly","year":"2016","unstructured":"Kahaly, G. J. et al. Thyroid stimulating antibodies are highly prevalent in Hashimoto\u2019s thyroiditis and associated Orbitopathy. J. Clin. Endocrinol. Metab. 101, 1998\u20132004. https:\/\/doi.org\/10.1210\/jc.2016-1220 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"98232_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1586\/17512433.2016.1165606","volume":"9","author":"M Ruchala","year":"2016","unstructured":"Ruchala, M. & Sawicka-Gutaj, N. Advances in the pharmacological treatment of Graves orbitopathy. Expert. Rev. Clin. Pharmacol. 9, 981\u2013989. https:\/\/doi.org\/10.1586\/17512433.2016.1165606 (2016).","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"98232_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s12020-015-0855-8","volume":"53","author":"N Sawicka-Gutaj","year":"2016","unstructured":"Sawicka-Gutaj, N. et al. Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves opthalmopathy. Endocrine 53, 497\u2013504. https:\/\/doi.org\/10.1007\/s12020-015-0855-8 (2016).","journal-title":"Endocrine"},{"key":"98232_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1316390","author":"N Sawicka-Gutaj","year":"2018","unstructured":"Sawicka-Gutaj, N. et al. Changes of nicotinamide phosphoribosyltransferase expressions in thyroid glands of patients with different thyroid pathologies. Biomed. Res. Int. https:\/\/doi.org\/10.1155\/2018\/1316390 (2018).","journal-title":"Biomed. Res. Int."},{"key":"98232_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","volume":"16","author":"PN Taylor","year":"2019","unstructured":"Taylor, P. N. et al. New insights into the pathogenesis and nonsurgical management of Graves orbitopathy. Nat. Rev. Endocrinol. 16, 104\u2013116. https:\/\/doi.org\/10.1038\/s41574-019-0305-4 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"98232_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-018-1018-5","volume":"19","author":"E Cyranska-Chyrek","year":"2019","unstructured":"Cyranska-Chyrek, E. et al. Severe unilateral orbitopathy in a patient with Hashimoto thyroiditis-a case report. BMC Ophthalmol. 19, 1\u20137. https:\/\/doi.org\/10.1186\/s12886-018-1018-5 (2019).","journal-title":"BMC Ophthalmol."},{"key":"98232_CR10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1515\/jpem-2016-0122","volume":"29","author":"J Szczapa-Jagustyn","year":"2016","unstructured":"Szczapa-Jagustyn, J., Gotz-Wieckowska, A. & Kociecki, J. An update on thyroid-associated ophthalmopathy in children and adolescents. J. Pediatr. Endocrinol. Metab. 29, 1115\u20131122. https:\/\/doi.org\/10.1515\/jpem-2016-0122 (2016).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"98232_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/754923","author":"E Kan","year":"2014","unstructured":"Kan, E., Kilickan, E., Gi, E., Beyazyildiz, E. & Colak, R. Presence of dry eye in patients with Hashimoto thyroiditis. J. Ophthalmol. https:\/\/doi.org\/10.1155\/2014\/754923 (2014).","journal-title":"J. Ophthalmol."},{"key":"98232_CR12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.ajo.2014.02.033","volume":"157","author":"SR Hatt","year":"2014","unstructured":"Hatt, S. R., Leske, D. A., Liebermann, L. & Holmes, J. M. Successful treatment of diplopia with prism improves health-related quality of life. Am. J. Ophthalmol. 157, 1209\u20131213. https:\/\/doi.org\/10.1016\/j.ajo.2014.02.033 (2014).","journal-title":"Am. J. Ophthalmol."},{"key":"98232_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fendo.2017.00184","volume":"8","author":"N Boddu","year":"2017","unstructured":"Boddu, N., Jumani, M., Wadhwa, V., Bajaj, G. & Faas, F. Not all orbitopathy is Graves: Discussion of cases and review of literature. Front. Endocrinol. 8, 184. https:\/\/doi.org\/10.3389\/fendo.2017.00184 (2017).","journal-title":"Front. Endocrinol."},{"key":"98232_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.amjmed.2010.11.006","volume":"124","author":"M Ruchala","year":"2011","unstructured":"Ruchala, M., Szczepanek, E., Puszczewicz, M., Sosnowski, P. & Sowinski, J. Not a graves\u2019 situation. Am. J. Med. 124, 210\u2013214. https:\/\/doi.org\/10.1016\/j.amjmed.2010.11.006 (2011).","journal-title":"Am. J. Med."},{"key":"98232_CR15","doi-asserted-by":"publisher","first-page":"NC01","DOI":"10.7860\/JCDR\/2017\/24541.9389","volume":"11","author":"SP Sah","year":"2017","unstructured":"Sah, S. P., Sharma, I. P., Chaudhry, M. & Saikia, M. Health-related quality of life (HRQoL) in young adults with strabismus in India. J. Clin. Diagn. Res. JCDR 11, NC01. https:\/\/doi.org\/10.7860\/JCDR\/2017\/24541.9389 (2017).","journal-title":"J. Clin. Diagn. Res. JCDR"},{"issue":"175\u2013182","key":"98232_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2010.06.043","volume":"151","author":"TM McClure","year":"2011","unstructured":"McClure, T. M. et al. The impact of eyeglasses on vision-related quality of life in American Indian\/Alaska Natives. Am. J. Ophthalmol. 151(175\u2013182), e172. https:\/\/doi.org\/10.1016\/j.ajo.2010.06.043 (2011).","journal-title":"Am. J. Ophthalmol."},{"key":"98232_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.5603\/EP.2015.0047","volume":"66","author":"N Sawicka-Gutaj","year":"2015","unstructured":"Sawicka-Gutaj, N. et al. ThyPROpl - The Polish version of the thyroid-specific quality of life questionnaire ThyPRO. Endokrynol. Pol. 66, 367\u2013380. https:\/\/doi.org\/10.5603\/EP.2015.0047 (2015).","journal-title":"Endokrynol. Pol."},{"key":"98232_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1530\/EJE-09-0521","volume":"162","author":"T Watt","year":"2010","unstructured":"Watt, T. et al. Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur. J. Endocrinol. 162, 161\u2013167. https:\/\/doi.org\/10.1530\/EJE-09-0521 (2010).","journal-title":"Eur. J. Endocrinol."},{"key":"98232_CR19","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1210\/jc.2014-1322","volume":"99","author":"T Watt","year":"2014","unstructured":"Watt, T. et al. The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J. Clin. Endocrinol. Metab. 99, 3708\u20133717. https:\/\/doi.org\/10.1210\/jc.2014-1322 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"98232_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena, L. et al. The 2016 European thyroid association\/European group on Graves\u2019 Orbitopathy guidelines for the Management of Graves\u2019 Orbitopathy. Eur. Thyroid J. 5, 9\u201326. https:\/\/doi.org\/10.1159\/000443828 (2016).","journal-title":"Eur. Thyroid J."},{"key":"98232_CR21","doi-asserted-by":"publisher","DOI":"10.1159\/isbn.978-3-8055-8343-5","volume-title":"Graves' Orbitopathy: A Multidisciplinary Approach","author":"WM Wiersinga","year":"2007","unstructured":"Wiersinga, W. M. & Kahaly, G. Graves\u2019 Orbitopathy: A Multidisciplinary Approach (Karger Medical and Scientific Publishers, 2007)."},{"issue":"483\u2013490","key":"98232_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.02.018","volume":"152","author":"KA Ponto","year":"2011","unstructured":"Ponto, K. A. et al. Quality of life in a german graves orbitopathy population. Am. J. Ophthalmol. 152(483\u2013490), e481. https:\/\/doi.org\/10.1016\/j.ajo.2011.02.018 (2011).","journal-title":"Am. J. Ophthalmol."},{"key":"98232_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.autrev.2017.12.012","volume":"17","author":"A Bruscolini","year":"2018","unstructured":"Bruscolini, A. et al. Quality of life and neuropsychiatric disorders in patients with Graves\u2019 orbitopathy: Current concepts. Autoimmun. Rev. 17, 639\u2013643. https:\/\/doi.org\/10.1016\/j.autrev.2017.12.012 (2018).","journal-title":"Autoimmun. Rev."},{"key":"98232_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156925","volume":"11","author":"KH Winther","year":"2016","unstructured":"Winther, K. H. et al. Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy. PLoS ONE 11, e0156925. https:\/\/doi.org\/10.1371\/journal.pone.0156925 (2016).","journal-title":"PLoS ONE"},{"key":"98232_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12020-018-1733-y","volume":"63","author":"CM Riguetto","year":"2019","unstructured":"Riguetto, C. M., Neto, A. M., Tambascia, M. A. N. & Zantut-Wittmann, D. E. The relationship between quality of life, cognition, and thyroid status in Graves disease. Endocrine 63, 87\u201393. https:\/\/doi.org\/10.1007\/s12020-018-1733-y (2019).","journal-title":"Endocrine"},{"key":"98232_CR26","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/hed.24886","volume":"39","author":"JR Sorensen","year":"2017","unstructured":"Sorensen, J. R. et al. Quality of life after thyroidectomy in patients with nontoxic nodular goiter: A prospective cohort study. Head Neck 39, 2232\u20132240. https:\/\/doi.org\/10.1002\/hed.24886 (2017).","journal-title":"Head Neck"},{"key":"98232_CR27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1089\/thy.2017.0602","volume":"28","author":"N Sawicka-Gutaj","year":"2018","unstructured":"Sawicka-Gutaj, N. et al. Patients with benign thyroid diseases experience an impaired sex life. Thyroid 28, 1261\u20131269. https:\/\/doi.org\/10.1089\/thy.2017.0602 (2018).","journal-title":"Thyroid"},{"key":"98232_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.20452\/pamw.4383","volume":"129","author":"N Sawicka-Gutaj","year":"2019","unstructured":"Sawicka-Gutaj, N. et al. Recurrent goiter: Risk factors, patient quality of life, and efficacy of radioiodine therapy. Pol. Arch. Intern. Med. 129, 22\u201327. https:\/\/doi.org\/10.20452\/pamw.4383 (2019).","journal-title":"Pol. Arch. Intern. Med."},{"key":"98232_CR29","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1089\/thy.2018.0315","volume":"29","author":"O Torring","year":"2019","unstructured":"Torring, O. et al. Impaired quality of life after radioiodine therapy compared to antithyroid drugs or surgical treatment for Graves\u2019 hyperthyroidism: A long-term follow-up with the thyroid-related patient-reported outcome questionnaire and 36-item short form health status survey. Thyroid 29, 322\u2013331. https:\/\/doi.org\/10.1089\/thy.2018.0315 (2019).","journal-title":"Thyroid"},{"key":"98232_CR30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00011-014-0739-z","volume":"63","author":"X Provatopoulou","year":"2014","unstructured":"Provatopoulou, X. et al. Interleukins as markers of inflammation in malignant and benign thyroid disease. Inflamm. Res. 63, 667\u2013674. https:\/\/doi.org\/10.1007\/s00011-014-0739-z (2014).","journal-title":"Inflamm. Res."},{"key":"98232_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/09273940701299362","volume":"15","author":"B Gopinath","year":"2007","unstructured":"Gopinath, B., Adams, C.-L., Musselman, R., Tani, J. & Wall, J. R. Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction. Ocul. Immunol. Inflamm. 15, 81\u201388. https:\/\/doi.org\/10.1080\/09273940701299362 (2007).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"98232_CR32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.33549\/physiolres.931989","volume":"60","author":"P Novak","year":"2011","unstructured":"Novak, P. & Soukup, T. Calsequestrin distribution, structure and function, its role in normal and pathological situations and the effect of thyroid hormones. Physiol. Res. 60, 439. https:\/\/doi.org\/10.33549\/physiolres.931989 (2011).","journal-title":"Physiol. Res."},{"key":"98232_CR33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2147\/opth.s6534","volume":"4","author":"H Lahooti","year":"2010","unstructured":"Lahooti, H., Parmar, K. R. & Wall, J. R. Pathogenesis of thyroid-associated ophthalmopathy: Does autoimmunity against calsequestrin and collagen XIII play a role?. Clin. Ophthalmol. 4, 417. https:\/\/doi.org\/10.2147\/opth.s6534 (2010).","journal-title":"Clin. Ophthalmol."},{"key":"98232_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12020-018-1649-6","volume":"62","author":"M Djurovic","year":"2018","unstructured":"Djurovic, M. et al. Cognitive functioning and quality of life in patients with Hashimoto thyroiditis on long-term levothyroxine replacement. Endocrine 62, 136\u2013143. https:\/\/doi.org\/10.1007\/s12020-018-1649-6 (2018).","journal-title":"Endocrine"},{"key":"98232_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijsu.2015.08.001","volume":"21","author":"VR Zivaljevic","year":"2015","unstructured":"Zivaljevic, V. R. et al. Quality of life improvement in patients with Hashimoto thyroiditis and other goiters after surgery: A prospective cohort study. Int. J. Surg. 21, 150\u2013155. https:\/\/doi.org\/10.1016\/j.ijsu.2015.08.001 (2015).","journal-title":"Int. J. Surg."},{"key":"98232_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.kjms.2016.06.006","volume":"32","author":"HB Uysal","year":"2016","unstructured":"Uysal, H. B. & Ayhan, M. Autoimmunity affects health-related quality of life in patients with Hashimoto\u2019s thyroiditis. Kaohsiung J. Med. Sci. 32, 427\u2013433. https:\/\/doi.org\/10.1016\/j.kjms.2016.06.006 (2016).","journal-title":"Kaohsiung J. Med. Sci."},{"key":"98232_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1530\/eje.1.02336","volume":"156","author":"M Abraham-Nordling","year":"2007","unstructured":"Abraham-Nordling, M., Wallin, G., Lundell, G. & Torring, O. Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Graves disease. Eur. J. Endocrinol. 156, 173\u2013179. https:\/\/doi.org\/10.1530\/eje.1.02336 (2007).","journal-title":"Eur. J. Endocrinol."},{"key":"98232_CR38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3760\/cma.j.issn.0578-1426.2019.08.006","volume":"58","author":"C Weng","year":"2019","unstructured":"Weng, C. et al. Evaluation of quality of life in patients with graves orbitopathy and its influencing factors. Zhonghua Nei Ke Za Zhi 58, 577\u2013583. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1426.2019.08.006 (2019).","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"98232_CR39","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00423-014-1221-7","volume":"399","author":"BR Bukvic","year":"2014","unstructured":"Bukvic, B. R. et al. Improvement of quality of life in patients with benign goiter after surgical treatment. Langenbecks Arch. Surg. 399, 755\u2013764. https:\/\/doi.org\/10.1007\/s00423-014-1221-7 (2014).","journal-title":"Langenbecks Arch. Surg."},{"key":"98232_CR40","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jfma.2013.12.002","volume":"114","author":"I-C Lin","year":"2015","unstructured":"Lin, I.-C., Lee, C.-C. & Liao, S.-L. Assessing quality of life in Taiwanese patients with Graves\u2019 ophthalmopathy. J. Formos. Med. Assoc. 114, 1047\u20131054. https:\/\/doi.org\/10.1016\/j.jfma.2013.12.002 (2015).","journal-title":"J. Formos. Med. Assoc."},{"key":"98232_CR41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.20883\/jms.323","volume":"88","author":"M Stanislawska-Kubiak","year":"2019","unstructured":"Stanislawska-Kubiak, M., Warchol-Biedermann, K., Skommer, M., Mojs, E. & Wojciak, R. W. The role of intra-and interpersonal relations in the process of diagnosis and treatment. J. Med. Sci. 88, 156\u2013162. https:\/\/doi.org\/10.20883\/jms.323 (2019).","journal-title":"J. Med. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98232-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98232-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98232-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T15:47:12Z","timestamp":1670082432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98232-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98232"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98232-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,21]]},"assertion":[{"value":"5 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18706"}}